“06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily”, EuroMed Bio J, vol. 21, no. s1, Nov. 2026, doi: 10.3269/q1nt4g06.